The Greater Cannabis Co., Inc. engages in the business of cannabis related investment and development opportunities through online retail store, direct equity investments, joint ventures, licensing agreements, or acquisitions. The company is headquartered in Baltimore, Maryland and currently employs 1 full-time employees. The company went IPO on 2018-07-09. The firm is involved in additional research and development of cannabinoid-based therapeutics that reduce disruptive symptoms in patients suffering from neuropsychiatric disorders. The firm also focuses on developing new formulations around cannabinoid therapeutics. Its wholly owned subsidiary is Biocanrx, Inc.
根据最新的财务报表(Form-10K),Greater Cannabis Company Inc 的总资产为 $0,净损失为 $0
GCAN 的关键财务比率是什么?
Greater Cannabis Company Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Greater Cannabis Company Inc 的收入按细分市场或地理位置如何划分?
Greater Cannabis Company Inc 最大收入来源是 Semiconductor & Electronics,在最近的收益报告中收入为 527,646,000,000。就地区而言, United States 是 Greater Cannabis Company Inc 的主要市场,收入为 398,905,000,000。